Amyloid-beta, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative Data


Por: Bos, I, Vos, SJB, Jansen, WJ, Vandenberghe, R, Gabel, S, Estanga, A, Ecay-Torres, M, Tomassen, J, den Braber, A, Lleo, A, Sala, I, Wallin, A, Kettunen, P, Molinuevo, JL, Rami, L, Chetelat, G, de la Sayette, V, Tsolaki, M, Freund-Levi, Y, Johannsen, P, Novak, GP, Ramakers, I, Verhey, FR, Visser, PJ

Publicada: 25 jun 2018
Resumen:
We investigated whether amyloid-beta (A beta) and tau affected cognition in cognitively normal (CN) individuals, and whether norms for neuropsychological tests based on biomarker-negative individuals would improve early detection of dementia. We included 907 CN individuals from 8 European cohorts and from the Alzheimer's disease Neuroimaging Initiative. All individuals were aged above 40, had A beta status and neuropsychological data available. Linear mixed models were used to assess the associations of Ali and tau with five neuropsychological tests assessing memory (immediate and delayed recall of Auditory Verbal Learning Test, AVLT), verbal fluency (Verbal Fluency Test, VFT), attention and executive functioning (Trail Making Test, TMT, part A and B). All test except the VFT were associated with status and this influence was augmented by age. We found no influence of tau on any of the cognitive tests. For the AVLT Immediate and Delayed recall and the TMT part A and B, we calculated norms in individuals without A beta pathology (A beta- norms), which we validated in an independent memory-clinic cohort by comparing their predictive accuracy to published norms. For memory tests, the A beta- norms rightfully identified an additional group of individuals at risk of dementia. For non-memory test we found no difference. We confirmed the relationship between Ao and cognition in cognitively normal individuals. The Af3- norms for memory tests in combination with published norms improve prognostic accuracy of dementia.

Filiaciones:
Bos, I:
 Maastricht Univ, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands

Vos, SJB:
 Maastricht Univ, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands

Jansen, WJ:
 Maastricht Univ, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands

Vandenberghe, R:
 Univ Hosp Leuven, Leuven, Belgium

 Katholieke Univ Leuven, Lab Cognit Neurol, Dept Neurosci, Leuven, Belgium

Gabel, S:
 Katholieke Univ Leuven, Lab Cognit Neurol, Dept Neurosci, Leuven, Belgium

 Katholieke Univ Leuven, Alzheimer Res Ctr, Leuven, Belgium

Estanga, A:
 CITA Alzheimer Fdn, Ctr Res & Adv Therapies, San Sebastian, Spain

Ecay-Torres, M:
 CITA Alzheimer Fdn, Ctr Res & Adv Therapies, San Sebastian, Spain

Tomassen, J:
 Vrije Univ Amsterdam, VU Univ Med Ctr, Alzheimer Ctr, Neurosci Campus Amsterdam, Amsterdam, Netherlands

 Vrije Univ Amsterdam, VU Univ Med Ctr, Dept Neurol, Neurosci Campus Amsterdam, Amsterdam, Netherlands

den Braber, A:
 Vrije Univ Amsterdam, VU Univ Med Ctr, Alzheimer Ctr, Neurosci Campus Amsterdam, Amsterdam, Netherlands

 Vrije Univ Amsterdam, VU Univ Med Ctr, Dept Neurol, Neurosci Campus Amsterdam, Amsterdam, Netherlands

 Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands

Lleo, A:
 Hosp Santa Creu & Sant Pau, Dept Neurol, Barcelona 9, Spain

Sala, I:
 Hosp Santa Creu & Sant Pau, Dept Neurol, Barcelona 9, Spain

Wallin, A:
 Univ Gothenburg, Sect Psychiat & Neurochem, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden

Kettunen, P:
 Univ Gothenburg, Sect Psychiat & Neurochem, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden

 Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England

Molinuevo, JL:
 Consorci Inst Invest Biomed August Pi I Sunyer ID, Alzheimers Dis & Other Cognit Disorders Unit, Hosp Clin, Barcelona, Spain

 Univ Pompeu Fabra, Barcelona Beta Brain Res Ctr, Barcelona, Spain

Rami, L:
 Consorci Inst Invest Biomed August Pi I Sunyer ID, Alzheimers Dis & Other Cognit Disorders Unit, Hosp Clin, Barcelona, Spain

Chetelat, G:
 Univ Caen Normandie, INSERM, UMR S U1237, GIP Cyceron, Caen, France

de la Sayette, V:
 Univ Caen Normandie, INSERM, U1077, Ecole Prat Hautes Etud, Caen, France

 CHU Caen, Serv Neurol, Caen, France

Tsolaki, M:
 Univ Gen Hosp Thessaloniki AHEPA, Dept Neurol 1, Thessaloniki, Greece

Freund-Levi, Y:
 Karolinska Inst, Dept Neurobiol Caring Sci & Soc NVS, Div Clin Geriatr, Stockholm, Sweden

 Karolinska Univ Hosp Huddinge, Karolinska Institutet, Dept Geriatr Med, Stockholm, Sweden

 Norrtalje Hosp Tiohundra, Dept Psychiat, Norrtalje, Sweden

Johannsen, P:
 Univ Copenhagen, Copenhagen Univ Hosp, Danish Dementia Res Ctr, Rigshosp, Copenhagen, Denmark

Novak, GP:
 Janssen Pharmaceut Res & Dev, Titusville, NJ USA

Ramakers, I:
 Maastricht Univ, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands

Verhey, FR:
 Maastricht Univ, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands

Visser, PJ:
 Maastricht Univ, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands

 Vrije Univ Amsterdam, VU Univ Med Ctr, Alzheimer Ctr, Neurosci Campus Amsterdam, Amsterdam, Netherlands

 Vrije Univ Amsterdam, VU Univ Med Ctr, Dept Neurol, Neurosci Campus Amsterdam, Amsterdam, Netherlands
ISSN: 16634365





Frontiers in Aging Neuroscience
Editorial
FRONTIERS MEDIA SA, AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND, Suiza
Tipo de documento: Article
Volumen: 10 Número:
Páginas:
WOS Id: 000436126300002
ID de PubMed: 29988624
imagen Green Published, gold

MÉTRICAS